M. Koenig, E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener et al., Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, vol.50, issue.3, pp.509-526, 1987.
DOI : 10.1016/0092-8674(87)90504-6

M. Koenig, A. Beggs, M. Moyer, S. Scherpf, K. Heindrich et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am J Hum Genet, vol.45, pp.498-506, 1989.

K. M. Bushby, M. Thambyayah, and D. Gardner-medwin, Prevalence and incidence of Becker muscular dystrophy, The Lancet, vol.337, issue.8748, pp.1022-1026, 1991.
DOI : 10.1016/0140-6736(91)92671-N

A. Aartsma-rus, J. C. Van-deutekom, I. F. Fokkema, G. J. Van-ommen, D. Dunnen et al., Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule, Muscle & Nerve, vol.56, issue.2, pp.135-179, 2006.
DOI : 10.1002/mus.20586

J. K. Mah, L. Korngut, J. Dykeman, L. Day, T. Pringsheim et al., A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy, Neuromuscular Disorders, vol.24, issue.6, pp.482-91, 2014.
DOI : 10.1016/j.nmd.2014.03.008

A. Beggs, E. Hoffman, J. Snyder, K. Arahata, L. Specht et al., Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies, Am J Hum Genet, vol.49, pp.54-67, 1991.

K. M. Bushby and D. Gardner-medwin, The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy, Journal of Neurology, vol.120, issue.2, pp.98-104, 1993.
DOI : 10.1007/BF00858725

G. P. Comi, A. Prelle, N. Bresolin, M. Moggio, A. Bardoni et al., Clinical variability in Becker muscular dystrophy Genetic, biochemical and immunohistochemical correlates, Brain, vol.117, issue.1, pp.117-118, 1994.
DOI : 10.1093/brain/117.1.1-a

C. L. Bladen, K. Rafferty, V. Straub, S. Monges, A. Moresco et al., The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia, The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia, pp.1449-57, 2013.
DOI : 10.1002/humu.22390

P. Melacini, M. Fanin, G. A. Danieli, G. Fasoli, C. Villanova et al., Cardiac involvement in becker muscular dystrophy, Journal of the American College of Cardiology, vol.22, issue.7, pp.1927-1961, 1993.
DOI : 10.1016/0735-1097(93)90781-U

J. Finsterer and C. Stollberger, Cardiac involvement in Becker muscular dystrophy, Canadian Journal of Cardiology, vol.24, issue.10, pp.786-92, 2008.
DOI : 10.1016/S0828-282X(08)70686-X

R. W. Kaspar, H. D. Allen, W. C. Ray, C. E. Alvarez, J. T. Kissel et al., Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy Cardiac assessment in duchenne and becker muscular dystrophies, Circ Cardiovasc Genet Romfh, A. and McNally, E.M. Curr Heart Fail Rep, vol.2, issue.7, pp.544-51, 2009.

M. Koenig, A. P. Monaco, and L. M. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, vol.53, issue.2, pp.219-226, 1988.
DOI : 10.1016/0092-8674(88)90383-2

L. Rumeur, E. Winder, S. J. Hubert, and J. F. , Dystrophin: More than just the sum of its parts, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1804, issue.9, pp.1713-1722, 2010.
DOI : 10.1016/j.bbapap.2010.05.001

URL : https://hal.archives-ouvertes.fr/hal-00592430

B. Legrand, E. Giudice, A. Nicolas, O. Delalande, and E. Lerumeur, Computational Study of the Human Dystrophin Repeats: Interaction Properties and Molecular Dynamics, PLoS ONE, vol.40, issue.8, p.23819, 2011.
DOI : 10.1371/journal.pone.0023819.s010

URL : https://hal.archives-ouvertes.fr/inserm-00689190

S. Tuffery-giraud, C. Beroud, F. Leturcq, R. B. Yaou, D. Hamroun et al., Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase, Human Mutation, vol.23, issue.6, pp.934-979, 2009.
DOI : 10.1002/humu.20976

A. Nicolas, C. Lucchetti-miganeh, B. Yaou, R. Kaplan, J. C. Chelly et al., Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.45, 2012.
DOI : 10.1016/S1525-1578(10)60560-0

URL : https://hal.archives-ouvertes.fr/inserm-00736304

N. Menhart, Hybrid spectrin type repeats produced by exon-skipping in dystrophin, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1764, issue.6, pp.993-999, 2006.
DOI : 10.1016/j.bbapap.2006.03.017

T. Yokota, W. Duddy, and T. Patridge, Optimizing exon skipping therapies for DMD, Acta myologica, vol.26, pp.179-184, 2007.

M. J. Sippl, Recognition of errors in three-dimensional structures of proteins, Proteins: Structure, Function, and Genetics, vol.177, issue.4, pp.355-62, 1993.
DOI : 10.1002/prot.340170404

M. Muthu, K. A. Richardson, and A. J. Sutherland-smith, The Crystal Structures of Dystrophin and Utrophin Spectrin Repeats: Implications for Domain Boundaries, PLoS ONE, vol.390, issue.7, p.40066, 2012.
DOI : 10.1371/journal.pone.0040066.s003

S. Legardinier, C. Raguénès-nicol, C. Tascon, C. Rocher, S. Hardy et al., Mapping of the Lipid-Binding and Stability Properties of the Central Rod Domain of Human Dystrophin, Journal of Molecular Biology, vol.389, issue.3, pp.546-558, 2009.
DOI : 10.1016/j.jmb.2009.04.025

URL : https://hal.archives-ouvertes.fr/inserm-00404317

S. Legardinier, J. Hubert, O. Le-bihan, C. Tascon, C. Rocher et al., Sub-domains of the dystrophin rod domain display contrasting lipid-binding and stability properties, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1784, issue.4, pp.672-682, 2008.
DOI : 10.1016/j.bbapap.2007.12.014

URL : https://hal.archives-ouvertes.fr/hal-00457831

F. Magri, A. Govoni, M. G. Angelo, D. Bo, R. Ghezzi et al., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up, Journal of Neurology, vol.4, issue.9, pp.1610-1633, 2011.
DOI : 10.1007/s00415-011-5979-z

K. Anthony, S. Cirak, S. Torelli, G. Tasca, L. Feng et al., Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials, Brain, vol.134, issue.12, pp.3544-56, 2011.
DOI : 10.1093/brain/awr291

S. Jarmin, H. Kymalainen, L. Popplewell, and G. Dickson, New developments in the use of gene therapy to treat Duchenne muscular dystrophy, Expert Opinion on Biological Therapy, vol.60, issue.5, pp.209-239, 2014.
DOI : 10.1002/humu.20918

S. D. Wilton, S. Fletcher, and K. M. Flanigan, Dystrophin as a therapeutic biomarker: Are we ignoring data from the past?, Neuromuscular Disorders, vol.24, issue.6, pp.463-466, 2014.
DOI : 10.1016/j.nmd.2014.03.007

L. Morandi, M. Mora, V. Confalonieri, R. Barresi, D. Blasi et al., Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy, J Neurol Sci J Neurol Neurosurg Psychiatry, vol.132, issue.85, pp.146-55, 1995.

K. M. Bushby, D. Gardner-medwin, L. V. Nicholson, M. A. Johnson, I. D. Haggerty et al., The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities Dystrophin levels and clinical severity in Becker muscular dystrophy patients, J Neurol J.J. J Neurol Neurosurg Psychiatry, vol.240, issue.85, pp.105-117, 1993.

A. Aartsma-rus, Dystrophin analysis in clinical trials, J Neuromuscul Dis, vol.1, issue.34, pp.41-53, 2014.

M. Neri, S. Torelli, S. Brown, I. Ugo, P. Sabatelli et al., Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human, Neuromuscular Disorders, vol.17, issue.11-12, pp.913-921, 2007.
DOI : 10.1016/j.nmd.2007.07.005

A. Carsana, G. Frisso, M. R. Tremolaterra, R. Lanzillo, D. F. Vitale et al., Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity, Annals of Human Genetics, vol.10, issue.3, pp.253-262, 2005.
DOI : 10.1046/J.1469-1809.2005.00160.x

S. Q. Harper, M. A. Hauser, C. Dellorusso, D. Duan, R. W. Crawford et al., Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy, Nature Medicine, vol.8, issue.3, pp.253-261, 2002.
DOI : 10.1038/nm0302-253

S. England, L. Nicholson, M. Johnson, S. Forrest, D. Love et al., Very mild muscular dystrophy associated with the deletion of 46% of dystrophin, Nature, vol.343, issue.6254, pp.180-182, 1990.
DOI : 10.1038/343180a0

A. Ferrer, H. Foster, K. E. Wells, G. Dickson, and D. J. Wells, Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins, Gene Therapy, vol.11, issue.11, pp.884-93, 2004.
DOI : 10.1038/sj.gt.3302242

R. A. Draviam, B. Wang, J. Li, X. Xiao, and S. C. Watkins, Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells, Journal of Muscle Research and Cell Motility, vol.74, issue.1, pp.53-67, 2006.
DOI : 10.1007/s10974-006-9055-8

Z. Wang, C. S. Kuhr, J. M. Allen, M. Blankinship, P. Gregorevic et al., Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin Genetic therapeutic approaches for Duchenne muscular dystrophy, Mol Ther Hum Mol Genet, vol.15, issue.23, pp.1160-1166, 2007.

D. M. Henderson, J. J. Belanto, B. Li, H. Heun-johnson, and J. M. Ervasti, Internal deletion compromises the stability of dystrophin, Human Molecular Genetics, vol.20, issue.15, pp.2955-63, 2011.
DOI : 10.1093/hmg/ddr199

S. J. Winder, T. J. Gibson, K. , and J. , Dystrophin and utrophin: the missing links! FEBS Letters, pp.27-33, 1995.

B. J. Petrof, J. B. Shrager, H. H. Stedmann, A. M. Kelly, and H. L. Sweeney, Dystrophin protects the sarcolemma from stresses developed during muscle contraction., Proceedings of the National Academy of Sciences, vol.90, issue.8, pp.3710-3714, 1993.
DOI : 10.1073/pnas.90.8.3710

N. Deconinck and B. Dan, Pathophysiology of Duchenne Muscular Dystrophy: Current Hypotheses, Pediatric Neurology, vol.36, issue.1, pp.1-7, 2007.
DOI : 10.1016/j.pediatrneurol.2006.09.016

A. Nicolas, O. Delalande, J. F. Hubert, L. Rumeur, and E. , The spectrin family of proteins: A unique coiled-coil fold for various molecular surface properties, Journal of Structural Biology, vol.186, issue.3, pp.392-401, 2014.
DOI : 10.1016/j.jsb.2014.03.011

URL : https://hal.archives-ouvertes.fr/hal-01020693

A. T. Helderman-van-den-enden, C. S. Straathof, A. Aartsma-rus, J. T. Den-dunnen, B. M. Verbist et al., Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients, Neuromuscular Disorders, vol.20, issue.4, pp.251-255, 2010.
DOI : 10.1016/j.nmd.2010.01.013

K. J. Amann, B. A. Renley, and J. M. Ervasti, A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction, Journal of Biological Chemistry, vol.273, issue.43, pp.28419-28423, 1998.
DOI : 10.1074/jbc.273.43.28419

J. M. Ervasti, Dystrophin, its interactions with other proteins, and implications for muscular dystrophy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1772, issue.2, pp.108-125, 2006.
DOI : 10.1016/j.bbadis.2006.05.010

URL : https://hal.archives-ouvertes.fr/hal-00562718

M. Schwartz, M. Duno, A. L. Palle, T. Krag, J. N. Vissing et al., Deletion of exon 16 of the dystrophin gene is not associated with disease Deletion of exon 26 of the dystrophin gene is associated with a mild Becker muscular dystrophy phenotype, Hum Mutat Acta Myol, vol.28, issue.30, pp.182-186, 2007.

Y. Lai, G. D. Thomas, Y. Yue, H. T. Yang, D. Li et al., Dystrophins carrying spectrin-like repeats 16, 2009.

E. Giudice, A. Molza, Y. Laurin, A. Nicolas, E. Le-rumeur et al., Molecular Clues about the Dystrophin???Neuronal Nitric Oxide Synthase Interaction: A Theoretical Approach, Biochemistry, vol.52, issue.44, pp.7777-84, 2013.
DOI : 10.1021/bi400794p

URL : https://hal.archives-ouvertes.fr/hal-00935150

C. Beroud, S. Tuffery-giraud, M. Matsuo, D. Hamroun, V. Humbertclaude et al., Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy, Human Mutation, vol.18, issue.Web Server issu, pp.196-202, 2007.
DOI : 10.1002/humu.20428

URL : https://hal.archives-ouvertes.fr/inserm-00381940

C. Gentil, F. Leturcq, R. Ben-yaou, J. C. Kaplan, P. Laforet et al., Variable phenotype of del45-55 Becker patients correlated with nNOS?? mislocalization and RYR1 hypernitrosylation, Human Molecular Genetics, vol.21, issue.15, pp.3449-60, 2012.
DOI : 10.1093/hmg/dds176

K. M. Flanigan, D. M. Dunn, A. Von-niederhausern, P. Soltanzadeh, E. Gappmaier et al., Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort, Human Mutation, vol.23, issue.12, pp.1657-1666, 2009.
DOI : 10.1002/humu.21114

D. Cacchiarelli, T. Incitti, J. Martone, M. Cesana, V. Cazzella et al., miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy, EMBO reports, vol.119, issue.2, pp.136-177, 2011.
DOI : 10.1161/CIRCRESAHA.108.183426

URL : https://hal.archives-ouvertes.fr/pasteur-00976757

B. Kerst, D. Mennerich, M. Schuelke, G. Stoltenburg-didinger, A. Von-moers et al., Heterozygous myogenic factor 6 mutation associated with myopathy and severe course of Becker muscular dystrophy, Neuromuscular Disorders, vol.10, issue.8, pp.572-579, 2000.
DOI : 10.1016/S0960-8966(00)00150-4

D. B. Davis, A. J. Delmonte, C. T. Ly, and E. M. Mcnally, Myoferlin, a candidate gene and potential modifier of muscular dystrophy, Human Molecular Genetics, vol.9, issue.2, pp.217-243, 2000.
DOI : 10.1093/hmg/9.2.217

E. Pegoraro, E. P. Hoffman, L. Piva, B. F. Gavassini, S. Cagnin et al., SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy, Neurology, vol.76, issue.3, pp.219-245, 2011.
DOI : 10.1212/WNL.0b013e318207afeb

L. Bello, L. Piva, A. Barp, A. Taglia, E. Picillo et al., Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy, Neurology, vol.79, issue.2, pp.159-62, 2012.
DOI : 10.1212/WNL.0b013e31825f04ea

A. Aartsma-rus, Antisense-mediated modulation of splicing: Therapeutic implications for Duchenne muscular dystrophy, RNA Biology, vol.7, issue.4, pp.453-61, 2010.
DOI : 10.4161/rna.7.4.12264

E. P. Hoffman, E. M. Connor, R. J. Fairclough, M. J. Wood, and K. E. Davies, Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches, Discov Med Nat Rev Genet, vol.16, issue.14, pp.233-242, 2013.

S. Ameziane-le-hir, C. Raguénès-nicol, G. Paboeuf, A. Nicolas, A. Chéron et al., Cholesterol favors the anchorage of human dystrophin repeats 16 to 21 in membrane at physiological surface pressure, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1838, issue.5, pp.1266-73, 2014.
DOI : 10.1016/j.bbamem.2014.01.010

URL : https://hal.archives-ouvertes.fr/hal-00965782

N. A. Baker, D. Sept, S. Joseph, M. J. Holst, and J. A. Mccammon, Electrostatics of nanosystems: Application to microtubules and the ribosome, Proceedings of the National Academy of Sciences, vol.98, issue.18, pp.10037-10078, 2001.
DOI : 10.1073/pnas.181342398

J. Felsenstein, Estimation of hominoid phylogeny from a DNA hybridization data set, Journal of Molecular Evolution, vol.3, issue.1-2, pp.123-154, 1987.
DOI : 10.1007/BF02111286

J. C. Phillips, R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid et al., Scalable molecular dynamics with NAMD, Journal of Computational Chemistry, vol.84, issue.16, pp.1781-802, 2005.
DOI : 10.1002/jcc.20289

N. Foloppe, A. D. Mackerell, and . Jr, All-atom empirical force field for nucleic acids: I. Parameter optimization based on small molecule and condensed phase macromolecular target data, Journal of Computational Chemistry, vol.7, issue.2, pp.86-104, 2000.
DOI : 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G

A. D. Mackerell, . Jr, and N. Banavali, All-atom empirical force field for nucleic acids: II. Application to molecular dynamics simulations of DNA and RNA in solution, Journal of Computational Chemistry, vol.6, issue.2, pp.105-120, 2000.
DOI : 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P

A. D. Mackerell, . Jr, M. Feig, and C. L. Brooks, Extending the treatment of backbone energetics in protein force fields: Limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations, Journal of Computational Chemistry, vol.44, issue.Pt 6 Pt 1, pp.1400-1415, 2004.
DOI : 10.1002/jcc.20065

R. G. Efremov, A. O. Chugunov, T. V. Pyrkov, J. P. Priestle, A. S. Arseniev et al., Molecular Lipophilicity in Protein Modeling and Drug Design, Current Medicinal Chemistry, vol.14, issue.4, pp.393-415, 2007.
DOI : 10.2174/092986707779941050

T. V. Pyrkov, A. O. Chugunov, N. A. Krylov, D. E. Nolde, R. G. Efremov et al., PLATINUM: a web tool for analysis of hydrophobic/hydrophilic organization of biomolecular complexes, Bioinformatics, vol.25, issue.9, pp.1201-1203, 1995.
DOI : 10.1093/bioinformatics/btp111

S. Legardinier, B. Legrand, C. Raguénès-nicol, A. Bondon, S. Hardy et al., A Two-amino Acid Mutation Encountered in Duchenne Muscular Dystrophy Decreases Stability of the Rod Domain 23 (R23) Spectrin-like Repeat of Dystrophin, Journal of Biological Chemistry, vol.284, issue.13, pp.8822-8832, 2009.
DOI : 10.1074/jbc.M805846200

URL : https://hal.archives-ouvertes.fr/inserm-00365879

L. V. Anderson and K. Davison, Multiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins, The American Journal of Pathology, vol.154, issue.4, pp.1017-1039, 1999.
DOI : 10.1016/S0002-9440(10)65354-0